Plasma drug binding: implications for anesthesiologists
Wood, M.
Anesthesia and Analgesia 65(7): 786-804
1986
ISSN/ISBN: 0003-2999 PMID: 3087239 Document Number: 282532
Document emailed within 1 workday
Related Documents
Wosilait, W.D. 1975: A theoretical analysis of the distribution of quinidine in the plasma: the relationship between protein binding and therapeutic drug levels Research Communications in Chemical Pathology and Pharmacology 12(1): 147-154Bender, K.I.; Lutsevich, N.F.; Lutsevich, A.N. 1991: The clinical and pharmacological significance of drug binding by blood plasma proteins in the mother-placenta-fetus system Vrachebnoe Delo 11: 35-41
Tanigawa, K.; Tanaka, K. 2001: Education of basic/advanced life support and emergency medicine for anesthesiologists: a survey of chairpersons at university department and newly board certified anesthesiologists Masui. Japanese Journal of Anesthesiology 50(6): 666-671
Kazama, T. 2013: The importance of anesthesiologists' responsibility in the adaption of the new drug and apparatus to clinical use Masui. Japanese Journal of Anesthesiology 62(4): 389
Manásková, P.; Mészárosová, A.; Liberda, J.; Voburka, Z.; Tichá, M.; Jonáková, V. 1999: Aggregated forms of heparin-binding and non-heparin-binding proteins of boar seminal plasma and their binding properties Folia Biologica 45(5): 193-201
Irita, K.; Yoshimura, H.; Sakaguchi, Y.; Takamatsu, C.; Tokuda, K. 2008: Risk and crisis management by anesthesiologists regarding 'Guidelines for Actions Against Intraoperative Critical Hemorrhage' published by the Japanese Society of Anesthesiologists and the Japan Society of Transfusion Medicine and Cell Therapy Masui. Japanese journal of anesthesiology 57(9): 1109-1116
Neubig, R.R.; Gantzos, R.D.; Brasier, R.S. 1985: Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry Molecular Pharmacology 28(5): 475-486
Urien, S.; Guez, D.; Thénot, A.; Tillement, J.P. 1989: Indapamide binding to alpha 1-acid glycoprotein: consequences on its blood distribution and plasma binding in disease states Progress in Clinical and Biological Research 300: 449-452
Urien, S.; Morin, D.; Rocher, I.; Tillement, J.P. 1989: Tertatolol high affinity binding to alpha 1-acid glycoprotein: stereospecificity and consequences on plasma binding in disease states Progress in Clinical and Biological Research 300: 453-456
Ho Ngoc-Ta Trung, A.; Sirois, G. 1987: Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios Pharmaceutica Acta Helvetiae 62(2): 61-64
Iwao, Y.; Kawashima, Y.; Seo, N.; Kobayashi, T.; Goto, Y.; Morita, K.; Irita, K.; Tsuzaki, K.; Dohi, S.; Tanaka, Y.; Shiraishi, Y.; Tozaki, Y.; Nakao, Y. 2002: Perioperative mortality and morbidity for the year 2000 in 532 Japanese Society of Anesthesiologists certified training hospitals: with a special reference to surgical sites--report of the Japan Society of Anesthesiologists Committee on Operating Room Safety Masui. Japanese journal of anesthesiology 51(7): 791-800
Krieg, M.; Bartsch, W.; Herzer, S.; Becker, H.; Voigt, K.D. 1977: Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy Acta Endocrinologica 86(1): 200-215
Phillips, D.R.; White, R.J.; Trist, H.; Cullinane, C.; Dean, D.; Crothers, D.M. 1990: New insight into drug-DNA interactions at individual drug binding sites probed by RNA polymerase during active transcription of the DNA Anti-Cancer Drug Design 5(1): 21-29
Zaller, N.; Mazhnaya, A.; Larney, S.; Islam, Z.; Shost, A.; Prokhorova, T.; Rybak, N.; Flanigan, T. 2015: Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care International Journal on Drug Policy 26(1): 37-42
Dettli, L. 1976: Prediction of drug elimination in renal disease based on drug concentration measurements in plasma and/or urine Arzneimittel-Forschung 26(6): 1254
Schiff, D.; Chan, G.; Stern, L. 1973: Clinical implications of bilirubin-albumin binding in the newborn Revue Canadienne de Biologie 32(Suppl): 135-138
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Richard, R. Brookman 1985: Rockville, MD National Institute on Drug Abuse, (ADM) 83-1152 ,Adolescent Peer Pressure. Theory, Correlates, and Program Implications for Drug Abuse Prevention (1983) Journal of Adolescent Health Care 6(1): 53-0
Dubois, N.; Muller, N.; Lapicque, F.; Gillet, P.; Netter, P.; Royer, R.J. 1993: Stereoselective protein binding of non-steroidal anti-inflammatory agents. Pharmacological implications Therapie 48(4): 335-339
Olson, J.M.; Junck, L.; Young, A.B.; Penney, J.B.; Mancini, W.R. 1988: Isoquinoline and peripheral-type benzodiazepine binding in gliomas: implications for diagnostic imaging Cancer Research 48(20): 5837-5841